{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:08:34Z","timestamp":1793084914487,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"World Class 300 Project","award":["S2367890 (S2416714)"],"award-info":[{"award-number":["S2367890 (S2416714)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Successful chemoprevention or chemotherapy is achieved through targeted delivery of prophylactic agents during initial phases of carcinogenesis or therapeutic agents to malignant tumors. Bacteria can be used as anticancer agents, but efforts to utilize attenuated pathogenic bacteria suffer from the risk of toxicity or infection. Lactic acid bacteria are safe to eat and often confer health benefits, making them ideal candidates for live vehicles engineered to deliver anticancer drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, we developed an effective bacterial drug delivery system for colorectal cancer (CRC) therapy using the lactic acid bacterium\n                      <jats:italic>Pediococcus pentosaceus<\/jats:italic>\n                      . It is equipped with dual gene cassettes driven by a strong inducible promoter that encode the therapeutic protein P8 fused to a secretion signal peptide and a complementation system. In an inducible CRC cell-derived xenograft mouse model, our synthetic probiotic significantly reduced tumor volume and inhibited tumor growth relative to the control. Mice with colitis-associated CRC induced by azoxymethane and dextran sodium sulfate exhibited polyp regression and recovered taxonomic diversity when the engineered bacterium was orally administered. Further, the synthetic probiotic modulated gut microbiota and alleviated the chemically induced dysbiosis. Correlation analysis demonstrated that specific bacterial taxa potentially associated with eubiosis or dysbiosis, such as\n                      <jats:italic>Akkermansia<\/jats:italic>\n                      or\n                      <jats:italic>Turicibacter<\/jats:italic>\n                      , have positive or negative relationships with other microbial members.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Taken together, our work illustrates that an effective and stable synthetic probiotic composed of\n                      <jats:italic>P. pentosaceus<\/jats:italic>\n                      and the P8 therapeutic protein can reduce CRC and contribute to rebiosis, and the validity and feasibility of cell-based designer biopharmaceuticals for both treating CRC and ameliorating impaired microbiota.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-021-01071-4","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T18:02:39Z","timestamp":1622052159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota"],"prefix":"10.1186","volume":"9","author":[{"given":"Yusook","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongku","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chull","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo-Sang","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai Yeub","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaekyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Kyeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-6992","authenticated-orcid":false,"given":"Jihyun F.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"issue":"10053","key":"1071_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang H. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459\u2013544. https:\/\/doi.org\/10.1016\/S0140-6736(16)31012-1.","journal-title":"Lancet."},{"issue":"5","key":"1071_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4161\/cbt.23761","volume":"14","author":"D Woods","year":"2013","unstructured":"Woods D, Turchi JJ. Chemotherapy induced DNA damage response convergence of drugs and pathways. Cancer Biol Ther. 2013;14(5):379\u201389. https:\/\/doi.org\/10.4161\/cbt.23761.","journal-title":"Cancer Biol Ther."},{"issue":"6","key":"1071_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nrd3186","volume":"9","author":"S Aggarwal","year":"2010","unstructured":"Aggarwal S. Targeted cancer therapies. Nat Rev Drug Discov. 2010;9(6):427\u20138. https:\/\/doi.org\/10.1038\/nrd3186.","journal-title":"Nat Rev Drug Discov."},{"issue":"7792","key":"1071_CR4","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/d41586-020-00199-x","volume":"577","author":"E Dolgin","year":"2020","unstructured":"Dolgin E. Microbe fighting with cancer. Nature. 2020;577(7792):S16\u20138. https:\/\/doi.org\/10.1038\/d41586-020-00199-x.","journal-title":"Nature."},{"issue":"4","key":"1071_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","volume":"16","author":"DT Riglar","year":"2018","unstructured":"Riglar DT, Silver PA. Engineering bacteria for diagnostic and therapeutic applications. Nat Rev Microbiol. 2018;16(4):214\u201325. https:\/\/doi.org\/10.1038\/nrmicro.2017.172.","journal-title":"Nat Rev Microbiol."},{"issue":"12","key":"1071_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727\u201343. https:\/\/doi.org\/10.1038\/s41568-018-0070-z.","journal-title":"Nat Rev Cancer."},{"issue":"8","key":"1071_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00284-019-01679-8","volume":"76","author":"A G\u00f3rska","year":"2019","unstructured":"G\u00f3rska A, Przystupski D, Niemczura MJ, Kulbacka J. Probiotic bacteria: A promising tool in cancer prevention and therapy. Current Microbiology. 2019;76(8):939\u201349. https:\/\/doi.org\/10.1007\/s00284-019-01679-8.","journal-title":"Current Microbiology."},{"issue":"24","key":"1071_CR8","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.3748\/wjg.v20.i24.7878","volume":"20","author":"L Zhong","year":"2014","unstructured":"Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014;20(24):7878\u201386. https:\/\/doi.org\/10.3748\/wjg.v20.i24.7878.","journal-title":"World J Gastroenterol."},{"issue":"9","key":"1071_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nbt.4248","volume":"36","author":"LG Berm\u00fadez-Humar\u00e1n","year":"2018","unstructured":"Berm\u00fadez-Humar\u00e1n LG, Langella P. Live bacterial biotherapeutics in the clinic. Nat Biotechnol. 2018;36(9):816\u20138. https:\/\/doi.org\/10.1038\/nbt.4248.","journal-title":"Nat Biotechnol."},{"issue":"10207","key":"1071_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0.","journal-title":"Lancet."},{"issue":"11","key":"1071_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.14348\/molcells.2019.0064","volume":"42","author":"BC An","year":"2019","unstructured":"An BC, Ryu Y, Yoon Y-S, Choi O, Park HJ, Kim TY, et al. Colorectal cancer therapy using a Pediococcus pentosaceus SL4 drug delivery system secreting lactic acid bacteria-derived Protein p8. Mol Cells. 2019;42(11):755\u201362. https:\/\/doi.org\/10.14348\/molcells.2019.0064.","journal-title":"Mol Cells."},{"issue":"3","key":"1071_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00217-007-0796-4","volume":"227","author":"P Semjonovs","year":"2008","unstructured":"Semjonovs P, Zikmanis P. Evaluation of novel lactose-positive and exopolysaccharide-producing strain of Pediococcus pentosaceus for fermented foods. Eur Food Res Technol. 2008;227(3):851\u20136. https:\/\/doi.org\/10.1007\/s00217-007-0796-4.","journal-title":"Eur Food Res Technol."},{"key":"1071_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/genomeA.01106-13","volume":"1","author":"SH Dantoft","year":"2013","unstructured":"Dantoft SH, Bielak M, Seo J, Chung M, Jensen R. Complete genome sequence of Pediococcus pentosaceus Strain SL4. Genome Announc. 2013;1:3\u20134.","journal-title":"Genome Announc."},{"issue":"3","key":"1071_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/AEM.62.3.936-941.1996","volume":"62","author":"SL Caldwell","year":"1996","unstructured":"Caldwell SL, McMahon DJ, Oberg CJ, Broadbent JR. Development and characterization of lactose-positive Pediococcus species for milk fermentation. Appl Environ Microbiol. 1996;62(3):936\u201341. https:\/\/doi.org\/10.1128\/AEM.62.3.936-941.1996.","journal-title":"Appl Environ Microbiol."},{"issue":"4-7","key":"1071_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0958-6946(01)00056-5","volume":"11","author":"TP Beresford","year":"2001","unstructured":"Beresford TP, Fitzsimons NA, Brennan NL, Cogan TM. Recent advances in cheese microbiology. Int Dairy J. 2001;11(4-7):259\u201374. https:\/\/doi.org\/10.1016\/S0958-6946(01)00056-5.","journal-title":"Int Dairy J."},{"issue":"10","key":"1071_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.nutres.2015.08.001","volume":"35","author":"V Dubey","year":"2015","unstructured":"Dubey V, Ghosh AR, Bishayee K, Khuda-Bukhsh AR. Probiotic Pediococcus pentosaceus strain GS4 alleviates azoxymethane-induced toxicity in mice. Nutr Res. 2015;35(10):921\u20139. https:\/\/doi.org\/10.1016\/j.nutres.2015.08.001.","journal-title":"Nutr Res."},{"issue":"6","key":"1071_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12223-019-00689-0","volume":"64","author":"B Ghosh","year":"2019","unstructured":"Ghosh B, Sukumar G, Ghosh AR. Purification and characterization of pediocin from probiotic Pediococcus pentosaceus GS4, MTCC 12683. Folia Microbiol. 2019;64(6):765\u201378. https:\/\/doi.org\/10.1007\/s12223-019-00689-0.","journal-title":"Folia Microbiol."},{"issue":"2","key":"1071_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12010-012-9995-y","volume":"169","author":"M Thirabunyanon","year":"2013","unstructured":"Thirabunyanon M, Hongwittayakorn P. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol. 2013;169(2):511\u201325. https:\/\/doi.org\/10.1007\/s12010-012-9995-y.","journal-title":"Appl Biochem Biotechnol."},{"key":"1071_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3389\/fmicb.2019.01050","volume":"10","author":"W Ma","year":"2019","unstructured":"Ma W, Mao Q, Xia W, Dong G, Yu C, Jiang F. Gut microbiota shapes the efficiency of cancer therapy. Front Microbiol. 2019;10:1050. https:\/\/doi.org\/10.3389\/fmicb.2019.01050.","journal-title":"Front Microbiol."},{"key":"1071_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41587-019-0180-5","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:848\u201357.","journal-title":"Nat Biotechnol."},{"issue":"4","key":"1071_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2307\/1942268","volume":"27","author":"JR Bray","year":"1957","unstructured":"Bray JR, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr. 1957;27(4):325\u201349. https:\/\/doi.org\/10.2307\/1942268.","journal-title":"Ecol Monogr."},{"issue":"6","key":"1071_CR22","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","journal-title":"Genome Biol."},{"issue":"1","key":"1071_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20(1):142\u201352. https:\/\/doi.org\/10.1200\/JCO.2002.20.1.142.","journal-title":"J Clin Oncol."},{"issue":"15_suppl","key":"1071_CR24","doi-asserted-by":"publisher","first-page":"TPS5617","DOI":"10.1200\/jco.2014.32.15_suppl.tps5617","volume":"32","author":"WK Huh","year":"2014","unstructured":"Huh WK, Brady WE, Moore KN, Lankes HA, Monk BJ, Aghajanian C, et al. A phase 2 study of live-attenuated Listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265). J Clin Oncol. 2014;32(15_suppl):TPS5617. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.tps5617.","journal-title":"J Clin Oncol."},{"issue":"2","key":"1071_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gendis.2016.01.003","volume":"3","author":"V Staedtke","year":"2016","unstructured":"Staedtke V, Roberts NJ, Bai RY, Zhou S. Clostridium novyi-NT in cancer therapy. Genes Dis. 2016;3(2):144\u201352. https:\/\/doi.org\/10.1016\/j.gendis.2016.01.003.","journal-title":"Genes Dis."},{"issue":"7","key":"1071_CR26","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.18632\/oncotarget.7045","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Xia Y, Chen H, Hong L, Feng J, Yang J, et al. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget. 2016;7(7):8432\u201340. https:\/\/doi.org\/10.18632\/oncotarget.7045.","journal-title":"Oncotarget."},{"issue":"10","key":"1071_CR27","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1084\/jem.20181939","volume":"216","author":"W Zhu","year":"2019","unstructured":"Zhu W, Miyata N, Winter MG, Arenales A, Hughes ER, Spiga L, et al. Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J Exp Med. 2019;216(10):2378\u201393. https:\/\/doi.org\/10.1084\/jem.20181939.","journal-title":"J Exp Med."},{"issue":"1","key":"1071_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","volume":"2","author":"CL Ho","year":"2018","unstructured":"Ho CL, Tan HQ, Chua KJ, Kang A, Lim KH, Ling KL, et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomed Eng. 2018;2(1):27\u201337. https:\/\/doi.org\/10.1038\/s41551-017-0181-y.","journal-title":"Nat Biomed Eng."},{"issue":"7","key":"1071_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25(7):1057\u201363. https:\/\/doi.org\/10.1038\/s41591-019-0498-z.","journal-title":"Nat Med."},{"key":"1071_CR30","doi-asserted-by":"publisher","unstructured":"An BC, Hong S, Park HJ, Kim BK, Ahn JY, Ryu Y, et al. Anti-colorectal cancer effects of probiotic-derived P8 Protein. Genes. 2019;10(8). https:\/\/doi.org\/10.3390\/genes10080624.","DOI":"10.3390\/genes10080624"},{"issue":"5","key":"1071_CR31","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1158\/1078-0432.CCR-09-2878","volume":"16","author":"X Dong","year":"2010","unstructured":"Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res. 2010;16(5):1442\u201351. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2878.","journal-title":"Clin Cancer Res."},{"issue":"15","key":"1071_CR32","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-06-0113","volume":"12","author":"B Rubio-Viqueira","year":"2006","unstructured":"Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12(15):4652\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0113.","journal-title":"Clin Cancer Res."},{"issue":"17","key":"1071_CR33","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1158\/1078-0432.CCR-11-0341","volume":"17","author":"I Garrido-Laguna","year":"2011","unstructured":"Garrido-Laguna I, Uson M, Rajeshkumar NV, Tan AC, De Oliveira E, Karikari C, et al. Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin Cancer Res. 2011;17(17):5793\u2013800. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0341.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"1071_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330\u20138. https:\/\/doi.org\/10.1038\/nrc1074.","journal-title":"Nat Rev Cancer."},{"key":"1071_CR35","doi-asserted-by":"publisher","unstructured":"Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408\u201319. https:\/\/doi.org\/10.1200\/JCO.2004.05.063.","DOI":"10.1200\/JCO.2004.05.063"},{"key":"1071_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41522-017-0034-1","volume":"3","author":"L Guthrie","year":"2017","unstructured":"Guthrie L, Gupta S, Daily J, Kelly L. Human microbiome signatures of differential colorectal cancer drug metabolism. NPJ Biofilms Microbiomes. 2017;3:27.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1071_CR37","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/s41467-019-13336-6","volume":"10","author":"P Praveschotinunt","year":"2019","unstructured":"Praveschotinunt P, Duraj-Thatte AM, Gelfat I, Bahl F, Chou DB, Joshi NS. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nat Commun. 2019;10:5580.","journal-title":"Nat Commun"},{"key":"1071_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2016","unstructured":"Zeng MY. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2016;10:18\u201326.","journal-title":"Mucosal Immunol."},{"issue":"6","key":"1071_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","volume":"15","author":"B Routy","year":"2018","unstructured":"Routy B, Gopalakrishnan V, Daill\u00e8re R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018;15(6):382\u201396. https:\/\/doi.org\/10.1038\/s41571-018-0006-2.","journal-title":"Nat Rev Clin Oncol."},{"issue":"22","key":"1071_CR40","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3748\/wjg.v18.i22.2867","volume":"18","author":"SM Jiang","year":"2012","unstructured":"Jiang SM, Wu JH, Jia L. Intervention of Mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts. World J Gastroenterol. 2012;18(22):2867\u201371. https:\/\/doi.org\/10.3748\/wjg.v18.i22.2867.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"1071_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12885-017-3677-7","volume":"17","author":"WJ Aston","year":"2017","unstructured":"Aston WJ, Hope DE, Nowak AK, Robinson BW, Lake RA, Lesterhuis WJ. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17(1):684. https:\/\/doi.org\/10.1186\/s12885-017-3677-7.","journal-title":"BMC Cancer."},{"issue":"2","key":"1071_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.radonc.2004.05.004","volume":"72","author":"CE R\u00fcbe","year":"2004","unstructured":"R\u00fcbe CE, Wilfert F, Uthe D, K\u00f6nig J, Liu L, Schuck A, et al. Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol. 2004;72(2):231\u201341. https:\/\/doi.org\/10.1016\/j.radonc.2004.05.004.","journal-title":"Radiother Oncol."},{"issue":"1","key":"1071_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/1471-2407-12-448","volume":"12","author":"K Yoshimi","year":"2012","unstructured":"Yoshimi K, Hashimoto T, Niwa Y, Hata K, Serikawa T, Tanaka T, et al. Use of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay. BMC Cancer. 2012;12(1):448. https:\/\/doi.org\/10.1186\/1471-2407-12-448.","journal-title":"BMC Cancer."},{"key":"1071_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","volume":"80","author":"AT Sougiannis","year":"2019","unstructured":"Sougiannis AT, VanderVeen BN, Enos RT, Velazquez KT, Bader JE, Carson M, et al. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun. 2019;80:44\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.020.","journal-title":"Brain Behav Immun."},{"issue":"1","key":"1071_CR45","doi-asserted-by":"publisher","first-page":"16643","DOI":"10.1038\/srep16643","volume":"5","author":"M Schneeberger","year":"2015","unstructured":"Schneeberger M, Everard A, G\u00f3mez-Valad\u00e9s AG, Matamoros S, Ram\u00edrez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5(1):16643. https:\/\/doi.org\/10.1038\/srep16643.","journal-title":"Sci Rep."},{"issue":"3","key":"1071_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","volume":"65","author":"MC Dao","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65(3):426\u201336. https:\/\/doi.org\/10.1136\/gutjnl-2014-308778.","journal-title":"Gut."},{"key":"1071_CR47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3389\/fmicb.2017.01765","volume":"8","author":"PD Cani","year":"2017","unstructured":"Cani PD, de Vos WM. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. https:\/\/doi.org\/10.3389\/fmicb.2017.01765.","journal-title":"Front Microbiol."},{"issue":"11","key":"1071_CR48","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","volume":"69","author":"L Wang","year":"2020","unstructured":"Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice. Gut. 2020;69(11):1988\u201397. https:\/\/doi.org\/10.1136\/gutjnl-2019-320105.","journal-title":"Gut."},{"issue":"10","key":"1071_CR49","doi-asserted-by":"publisher","first-page":"e76520","DOI":"10.1371\/journal.pone.0076373","volume":"8","author":"KC Sung","year":"2013","unstructured":"Sung KC, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK, et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One. 2013;8(10):e76520.","journal-title":"PLoS One"},{"key":"1071_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fcimb.2019.00239","volume":"9","author":"R Zhai","year":"2019","unstructured":"Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol. 2019;9:239. https:\/\/doi.org\/10.3389\/fcimb.2019.00239.","journal-title":"Front Cell Infect Microbiol."},{"issue":"Pt 4","key":"1071_CR51","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1099\/00207713-52-4-1263","volume":"52","author":"PP Bosshard","year":"2002","unstructured":"Bosshard PP, Zbinden R, Altwegg M. Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. Int J Syst Evol Microbiol. 2002;52(Pt 4):1263\u20136. https:\/\/doi.org\/10.1099\/00207713-52-4-1263.","journal-title":"Int J Syst Evol Microbiol."},{"key":"1071_CR52","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1128\/JB.01328-10","volume":"193","author":"P O\u2019Cu\u00edv","year":"2011","unstructured":"O\u2019Cu\u00edv P, Klaassens ES, Durkin AS, Harkins DM, Foster L, McCorrison J, et al. Draft genome sequence of Turicibacter sanguinis PC909, isolated from human feces. J Bacteriol. 2011;193:1288\u20139.","journal-title":"J Bacteriol."},{"issue":"5","key":"1071_CR53","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1096\/fj.10-172205","volume":"25","author":"R Kellermayer","year":"2011","unstructured":"Kellermayer R, Dowd SE, Harris RA, Balasa A, Schaible TD, Wolcott RD, et al. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 2011;25(5):1449\u201360. https:\/\/doi.org\/10.1096\/fj.10-172205.","journal-title":"FASEB J."},{"issue":"7","key":"1071_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005008","volume":"11","author":"P Rausch","year":"2015","unstructured":"Rausch P, Steck N, Suwandi A, Seidel JA, K\u00fcnzel S, Bhullar K, et al. Expression of the bood-goup-related gene B4galnt2 alters susceptibility to Salmonella Infection. PLoS Pathog. 2015;11(7):e1005008. https:\/\/doi.org\/10.1371\/journal.ppat.1005008.","journal-title":"PLoS Pathog."},{"issue":"2","key":"1071_CR55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1758-2229.2012.00393.x","volume":"5","author":"PA Dimitriu","year":"2013","unstructured":"Dimitriu PA, Boyce G, Samarakoon A, Hartmann M, Johnson P, Mohn WW. Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity. Environ Microbiol Rep. 2013;5(2):200\u201310. https:\/\/doi.org\/10.1111\/j.1758-2229.2012.00393.x.","journal-title":"Environ Microbiol Rep."},{"issue":"6","key":"1071_CR56","doi-asserted-by":"publisher","first-page":"e00692","DOI":"10.1128\/mBio.00692-13","volume":"4","author":"JP Zackular","year":"2013","unstructured":"Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio. 2013;4(6):e00692\u201313. https:\/\/doi.org\/10.1128\/mBio.00692-13.","journal-title":"MBio."},{"issue":"1","key":"1071_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00535-018-1488-5","volume":"54","author":"T Takagi","year":"2019","unstructured":"Takagi T, Naito Y, Inoue R, Kashiwagi S, Uchiyama K, Mizushima K, et al. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol. 2019;54(1):53\u201363. https:\/\/doi.org\/10.1007\/s00535-018-1488-5.","journal-title":"J Gastroenterol."},{"issue":"3","key":"1071_CR58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.bjc.6605780","volume":"103","author":"K Bracht","year":"2010","unstructured":"Bracht K, Nicholls AM, Liu Y, Bodmer WF. 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency. Br J Cancer. 2010;103(3):340\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6605780.","journal-title":"Br J Cancer."},{"issue":"4","key":"1071_CR59","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/annonc\/mdh134","volume":"15","author":"K Patel","year":"2004","unstructured":"Patel K, Anthoney DA, Crellin AM, Sebag-Montefiore D, Messruther J, Seymour MT. Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection. Ann Oncol. 2004;15(4):568\u201373. https:\/\/doi.org\/10.1093\/annonc\/mdh134.","journal-title":"Ann Oncol."},{"issue":"4","key":"1071_CR60","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","volume":"20","author":"Y Touil","year":"2014","unstructured":"Touil Y, Igoudjil W, Corvaisier M, Dessein AF, Vandomme J, Monte D, et al. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis. Clin Cancer Res. 2014;20(4):837\u201346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1854.","journal-title":"Clin Cancer Res."},{"issue":"15","key":"1071_CR61","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1200\/JCO.2009.25.2106","volume":"28","author":"V Boige","year":"2010","unstructured":"Boige V, Mendiboure J, Pignon JP, Loriot MA, Castaing M, Barrois M, et al. Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. J Clin Oncol. 2010;28(15):2556\u201364. https:\/\/doi.org\/10.1200\/JCO.2009.25.2106.","journal-title":"J Clin Oncol."},{"issue":"1","key":"1071_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00253-006-0792-9","volume":"75","author":"T L\u00fctke-Eversloh","year":"2007","unstructured":"L\u00fctke-Eversloh T, Stephanopoulos G. L-Tyrosine production by deregulated strains of Escherichia coli. Appl Microbiol Biotechnol. 2007;75(1):103\u201310. https:\/\/doi.org\/10.1007\/s00253-006-0792-9.","journal-title":"Appl Microbiol Biotechnol."},{"issue":"14","key":"1071_CR63","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh K, Misawa K, Kuma KI, Miyata T. MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30(14):3059\u201366. https:\/\/doi.org\/10.1093\/nar\/gkf436.","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"1071_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price MN, Dehal PS, Arkin AP. FastTree 2 - Approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. https:\/\/doi.org\/10.1371\/journal.pone.0009490.","journal-title":"PLoS One."}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-021-01071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-021-01071-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-021-01071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T01:38:14Z","timestamp":1634175494000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-021-01071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1186\/s40168-021-01071-4","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MJC is the chief executive officer of Cell Biotech, Co., Ltd., and YR, BCA, Y-SY, OC, TYK, JYA, and HJP are employees of the company. JFK was the principal investigator for a contract research project of the World Class 300 Project awarded to Cell Biotech. YC worked for Cell Biotech before she became a full-time graduate student at Yonsei University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}